药师帮2025年收入与利润双增长，经营表现稳步提升

公告速递

Yesterday

截至2025年12月31日，药师帮全年实现收入人民币209.6965亿元，同比增长17.1%。其中，自营业务收入为人民币200.65552亿元，较上一年度提升18.2%；平台业务收入为人民币8.66025亿元，同比下降1.7%；其他业务收入为人民币0.38073亿元，同比下降23.3%。

报告期内，毛利达到人民币23.06982亿元，较2024年的人民币18.13451亿元增长27.2%，整体毛利率由10.1%提升至11.0%。年内利润为人民币1.45982亿元，高于上一年度的人民币0.15081亿元；经调整净利润为人民币2.37058亿元，同比增加51.2%。基本每股收益为人民币0.224元，摊薄每股收益为人民币0.220元。

在主要费用方面，销售及营销费用由人民币14.612亿元升至17.433亿元，同比增长19.3%；一般行政及管理费用由人民币3.54亿元增至4.045亿元，增幅14.3%；研发费用则由人民币0.942亿元增加至0.957亿元。经营活动所得现金净额为人民币6.377亿元，较上年同期下降约2.8%；年末现金及现金等价物为人民币7.09959亿元，同比减少31.8%。截至2025年12月31日，资产总额达人民币60.01211亿元，净资产为人民币23.86193亿元，相较上一年末增加约5.2%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1183439109"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183439109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183439109?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-23 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183439109","market":"us","top_or_hot":-1,"title":"药师帮2025年收入与利润双增长，经营表现稳步提升","media":"公告速递","content":"<p>截至2025年12月31日，药师帮全年实现收入人民币209.6965亿元，同比增长17.1%。其中，自营业务收入为人民币200.65552亿元，较上一年度提升18.2%；平台业务收入为人民币8.66025亿元，同比下降1.7%；其他业务收入为人民币0.38073亿元，同比下降23.3%。</p>\n<p>报告期内，毛利达到人民币23.06982亿元，较2024年的人民币18.13451亿元增长27.2%，整体毛利率由10.1%提升至11.0%。年内利润为人民币1.45982亿元，高于上一年度的人民币0.15081亿元；经调整净利润为人民币2.37058亿元，同比增加51.2%。基本每股收益为人民币0.224元，摊薄每股收益为人民币0.220元。</p>\n<p>在主要费用方面，销售及营销费用由人民币14.612亿元升至17.433亿元，同比增长19.3%；一般行政及管理费用由人民币3.54亿元增至4.045亿元，增幅14.3%；研发费用则由人民币0.942亿元增加至0.957亿元。经营活动所得现金净额为人民币6.377亿元，较上年同期下降约2.8%；年末现金及现金等价物为人民币7.09959亿元，同比减少31.8%。截至2025年12月31日，资产总额达人民币60.01211亿元，净资产为人民币23.86193亿元，相较上一年末增加约5.2%。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药师帮2025年收入与利润双增长，经营表现稳步提升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药师帮2025年收入与利润双增长，经营表现稳步提升\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1097772564\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">公告速递 </p>\n<p class=\"h-time\">2026-03-23 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>截至2025年12月31日，药师帮全年实现收入人民币209.6965亿元，同比增长17.1%。其中，自营业务收入为人民币200.65552亿元，较上一年度提升18.2%；平台业务收入为人民币8.66025亿元，同比下降1.7%；其他业务收入为人民币0.38073亿元，同比下降23.3%。</p>\n<p>报告期内，毛利达到人民币23.06982亿元，较2024年的人民币18.13451亿元增长27.2%，整体毛利率由10.1%提升至11.0%。年内利润为人民币1.45982亿元，高于上一年度的人民币0.15081亿元；经调整净利润为人民币2.37058亿元，同比增加51.2%。基本每股收益为人民币0.224元，摊薄每股收益为人民币0.220元。</p>\n<p>在主要费用方面，销售及营销费用由人民币14.612亿元升至17.433亿元，同比增长19.3%；一般行政及管理费用由人民币3.54亿元增至4.045亿元，增幅14.3%；研发费用则由人民币0.942亿元增加至0.957亿元。经营活动所得现金净额为人民币6.377亿元，较上年同期下降约2.8%；年末现金及现金等价物为人民币7.09959亿元，同比减少31.8%。截至2025年12月31日，资产总额达人民币60.01211亿元，净资产为人民币23.86193亿元，相较上一年末增加约5.2%。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09885","symbol_name":"药师帮","start_time":0,"source_url":"","article_id":"1183439109","we_media_id":"1097772564","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183439109","pubTimestamp":1774255554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"公告速递","introduction":"港美股公告全覆盖","home_visible":1,"id":"1097772564","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"截至2025年12月31日，药师帮全年实现收入人民币209.6965亿元，同比增长17.1%。其中，自营业务收入为人民币200.65552亿元，较上一年度提升18.2%；平台业务收入为人民币8.66025亿元，同比下降1.7%；其他业务收入为人民币0.38073亿元，同比下降23.3%。年内利润为人民币1.45982亿元，高于上一年度的人民币0.15081亿元；经调整净利润为人民币2.37058亿元，同比增加51.2%。截至2025年12月31日，资产总额达人民币60.01211亿元，净资产为人民币23.86193亿元，相较上一年末增加约5.2%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09885":"药师帮"},"translate_title":"Yaoshibang's revenue and profit will grow in 2025, and its operating performance will steadily improve","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09885":1},"content_text":"截至2025年12月31日，药师帮全年实现收入人民币209.6965亿元，同比增长17.1%。其中，自营业务收入为人民币200.65552亿元，较上一年度提升18.2%；平台业务收入为人民币8.66025亿元，同比下降1.7%；其他业务收入为人民币0.38073亿元，同比下降23.3%。\n报告期内，毛利达到人民币23.06982亿元，较2024年的人民币18.13451亿元增长27.2%，整体毛利率由10.1%提升至11.0%。年内利润为人民币1.45982亿元，高于上一年度的人民币0.15081亿元；经调整净利润为人民币2.37058亿元，同比增加51.2%。基本每股收益为人民币0.224元，摊薄每股收益为人民币0.220元。\n在主要费用方面，销售及营销费用由人民币14.612亿元升至17.433亿元，同比增长19.3%；一般行政及管理费用由人民币3.54亿元增至4.045亿元，增幅14.3%；研发费用则由人民币0.942亿元增加至0.957亿元。经营活动所得现金净额为人民币6.377亿元，较上年同期下降约2.8%；年末现金及现金等价物为人民币7.09959亿元，同比减少31.8%。截至2025年12月31日，资产总额达人民币60.01211亿元，净资产为人民币23.86193亿元，相较上一年末增加约5.2%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}